21 results
8-K
EX-99.3
IVVD
Invivyd Inc
22 Mar 24
Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19
8:58pm
and Medicaid Provider and Supplier Enrollment Policies; and Basic Health Program, November 16, 2023. https://www.federalregister.gov/documents/2023/11
10-K
14mym 4k8l8
31 Mar 22
Annual report
8:18am
10-Q
a10nyr7x s4rdk09l8w
20 Sep 21
Quarterly report
4:17pm
10-Q
EX-10.5
lzwilrchz8ip8zy
20 Sep 21
Quarterly report
4:17pm
424B4
3l2dcubqylii0
6 Aug 21
Prospectus supplement with pricing info
4:54pm
S-1/A
dhi7v
2 Aug 21
IPO registration (amended)
6:20am
S-1
0oc5j9n
16 Jul 21
IPO registration
4:56pm
S-1
EX-10.7
otpd73t4n61n1glcy2n
16 Jul 21
IPO registration
4:56pm
DRS/A
EX-10.7
ulgz4 osxcp7uf
13 Jul 21
Draft registration statement (amended)
12:00am
DRSLTR
3m2ghum7helijqe
28 Jun 21
Correspondence regarding draft registration statement
12:00am
DRS/A
0enh0k8
28 Jun 21
Draft registration statement (amended)
12:00am
UPLOAD
zkbqw4gon
16 Jun 21
Letter from SEC
12:00am